These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9624234)

  • 1. Endocrine treatment of hepatocellular carcinoma. Any evidence of benefit?
    Pignata S; Daniele B; Gallo C; De Vivo R; Monfardini S; Perrone F
    Eur J Cancer; 1998 Jan; 34(1):25-32. PubMed ID: 9624234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is human hepatocellular carcinoma a hormone-responsive tumor?
    Di Maio M; Daniele B; Pignata S; Gallo C; De Maio E; Morabito A; Piccirillo MC; Perrone F
    World J Gastroenterol; 2008 Mar; 14(11):1682-9. PubMed ID: 18350599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal treatment of human hepatocellular carcinoma.
    Di Maio M; De Maio E; Morabito A; D'Aniello R; De Feo G; Gallo C; Perrone F
    Ann N Y Acad Sci; 2006 Nov; 1089():252-61. PubMed ID: 17261772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current topics and perspectives in the treatment of endocrine-related cancers.
    Iwase H
    Int J Clin Oncol; 2008 Oct; 13(5):377-9. PubMed ID: 18946746
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy and medical treatment of hepatocellular carcinoma (HCC).
    Rougier P; Mitry E; Clavero-Fabri MC
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1264-6. PubMed ID: 9730386
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered androgen metabolism eventually leads hepatocellular carcinoma to an impaired hormone responsiveness.
    Granata OM; Carruba G; Montalto G; Miele M; Bellavia V; Modica G; Blomquist CH; Castagnetta LA
    Mol Cell Endocrinol; 2002 Jul; 193(1-2):51-8. PubMed ID: 12161001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-steroids and primary hepatocellular carcinoma.
    Wilkinson ML
    Anticancer Res; 1987; 7(5B):1071-7. PubMed ID: 2829701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen in hepatocellular carcinoma.
    Chow P; Kiat TC; Choo TB; Machin D
    Lancet; 1998 Sep; 352(9130):819-20. PubMed ID: 9737316
    [No Abstract]   [Full Text] [Related]  

  • 9. Sex hormones and liver cancer.
    De Maria N; Manno M; Villa E
    Mol Cell Endocrinol; 2002 Jul; 193(1-2):59-63. PubMed ID: 12161002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine therapy: where do we stand and where are we going?
    Schröder FH
    Cancer Surv; 1991; 11():177-94. PubMed ID: 1841751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of tamoxifen in hepatocellular carcinoma: a review and paradigm shift.
    Tan CK; Chow PK; Findlay M; Wong C; Machin D
    J Gastroenterol Hepatol; 2000 Jul; 15(7):725-9. PubMed ID: 10937676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of estrogen receptors in hepatocellular carcinoma and its response to anti-estrogen therapy].
    Zheng T; Zhang Q; Xie Z
    Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):451-3. PubMed ID: 10920881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma and sex hormones.
    Nagasue N; Kohno H
    HPB Surg; 1992; 6(1):1-6. PubMed ID: 1334694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.
    Kalra M; Mayes J; Assefa S; Kaul AK; Kaul R
    World J Gastroenterol; 2008 Oct; 14(39):5945-61. PubMed ID: 18932272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of Sex Hormone Receptor Gene Expression in the Predominance of Hepatocellular Carcinoma in Males: Role of Natural Products.
    Ahmed HH; Shousha WG; Shalby AB; El-Mezayen HA; Ismaiel NN; Mahmoud NS
    Asian Pac J Cancer Prev; 2015; 16(12):4949-54. PubMed ID: 26163620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors.
    Villa E; Ferretti I; Grottola A; Buttafoco P; Buono MG; Giannini F; Manno M; Bertani H; Dugani A; Manenti F
    Br J Cancer; 2001 Apr; 84(7):881-5. PubMed ID: 11286465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study.
    Liu CL; Fan ST; Ng IO; Lo CM; Poon RT; Wong J
    Am J Gastroenterol; 2000 Jan; 95(1):218-22. PubMed ID: 10638587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A therapeutic study of hepatocellular carcinoma using octreotide (HECTOR). Hepatocellular Carcinoma: Treatment with Octreotide].
    Allgaier HP; Becker G; Blum HE
    Dtsch Med Wochenschr; 2000 Mar; 125(11):320. PubMed ID: 10761474
    [No Abstract]   [Full Text] [Related]  

  • 19. [Does anti-estrogen therapy after estrogen receptor analysis have value in palliative therapy of hepatocellular carcinoma?].
    Kreysel C; Porschen R
    Z Gastroenterol; 1998 Jul; 36(7):605-7. PubMed ID: 9738309
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth factors, endocrine aspects and hormonal treatment in hepatocellular carcinoma--an overview.
    d'Arville CN; Johnson PJ
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1007-12. PubMed ID: 2178361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.